Buy Facebook Reviews
➤Email: usasmmit@gmail.com
➤Skype: usasmmit
➤Telegram: @usasmmit
➤WhatsApp: +1 (203) 433-2801
https://usasmmit.com/service/buy-facebook-reviews/
Kao
Komentar
Udio
Otkriti postovi
Buy Google Reviews
➤Email: usasmmit@gmail.com
➤Skype: usasmmit
➤Telegram: @usasmmit
➤WhatsApp: +1 (203) 433-2801
https://usasmmit.com/service/buy-google-reviews/
Kao
Komentar
Udio
Buy TrustPilot Reviews
➤Email: usasmmit@gmail.com
➤Skype: usasmmit
➤Telegram: @usasmmit
➤WhatsApp: +1 (203) 433-2801
https://usasmmit.com/service/b....uy-trustpilot-review
Kao
Komentar
Udio
Buy 5 Star Google Reviews
➤Email: usasmmit@gmail.com
➤Skype: usasmmit
➤Telegram: @usasmmit
➤WhatsApp: +1 (203) 433-2801
https://usasmmit.com/service/b....uy-5-star-google-rev
Kao
Komentar
Udio
Buy Google Reviews
➤Email: usasmmit@gmail.com
➤Skype: usasmmit
➤Telegram: @usasmmit
➤WhatsApp: +1 (203) 433-2801
https://usasmmit.com/service/buy-google-reviews/
Kao
Komentar
Udio
Excimer and Femtosecond Ophthalmic Lasers Market: Notable Developments & Geographical Outlook
The global excimer and femtosecond ophthalmic lasers market is projected to rise at a robust pace of 8.0% CAGR over the assessment years from 2022 to 2032. The global market reached US$ 1.02 Bn in 2021 and is expected to touch a valuation of US$ 1.18 Bn by the end of 2022. The global market is anticipated to exceed a valuation of US$ 2.41 Bn by 2032.
The growth in the global excimer and femtosecond ophthalmic lasers market is attributed to the increasing prevalence of eye diseases across the world and the surging adoption of ophthalmic lasers, the overall sales of excimer and femtosecond ophthalmic lasers are projected to rise.
An excimer laser is known as a form of ultraviolet laser which is commonly utilized in ophthalmic surgeries. Excimer laser photorefractive keratectomy and excimer laser in-situ keratomileusis (LASIK) are some of the most common procedures conducted using a laser which is used to rectify refractive errors of the eye, as excimer laser alters the refractive state of the eye by removing tissue from the anterior cornea.
On the basis of application, the refractive surgeries segment dominated the global Excimer and Femtosecond Ophthalmic Lasers Market with a total value share of nearly 69% in 2021.
The excimer and femtosecond ophthalmic lasers are prominently used in surgical care for treating numerous eye disorders on account of their safe, precise, and accurate nature. Attributing to such attractive benefits and technological advancements, excimer and femtosecond ophthalmic lasers have the potential to become the gold standard of eye surgeries.
The increasing prevalence of multiple eye disorders such as glaucoma, macular degeneration, and dia****ic retinopathy along with a surge in the number of eye surgeries performed worldwide is expected to bolster the growth of the Excimer and Femtosecond Ophthalmic Lasers Market during the assessment period.
Key Takeaways
An increase in the opening of ophthalmology clinics and hospitals in many nations all over the world is expected to propel growth in the market. Due to the rise in the number of elderly people visiting ophthalmology clinics and hospitals as well as the large numbers of dia****ic people who have eye disease or are at risk of developing it. These aforementioned factors are anticipated to grow femtosecond and excimer ophthalmic laser market growth during the next ten years.
The government and several other regulatory bodies are meticulously working in order to make eye care services a crucial part of universal health coverage and address the increasing impact of vision loss on sustainable development. This is expected to create lucrative growth prospects within the global excimer and femtosecond laser market.
In order to provide ophthalmologists with some of the best equipment possible to efficiently perform delicate eye procedures, ophthalmic laser manufacturers are constantly improving their laser systems.
In comparison to manual surgery, Femtosecond laser cutting is done with greater precision and accuracy. Growth in the global excimer & femtosecond ophthalmic lasers market is mainly driven by the increasing dia****ic and aging population globally. This increase is resulting in a rise in the number of common ophthalmic disorders such as cataracts, glaucoma, etc.
The surge in the prevalence of age-related macular degeneration (AMD), glaucoma, cataract, dia****ic retinopathy, and presbyopia require surgical correction to restore normal vision. Therefore, the increased aging and dia****ic population is a major factor expected to fuel the growth of the global Excimer and Femtosecond Ophthalmic Lasers Market over the forecast period.
Competitive Landscape
The prominent market players in the healthcare sector are utilizing FLACS, or femtosecond laser-aided cataract surgery, as a safe and efficient therapy option for elderly patients, which is rapidly gaining ground. Hand-held surgical instruments in several procedures such as cataract fragmentation, anterior capsulotomy, and corneal incision are being drastically replaced by more efficient lasers resulting in increased accuracy and precision.
Key Companies Profiled: –
Medtronic Public Limited Company, Boston Scientific Corp, St Jude Medical LLC and Nevro Corp, Nuvectra Corporation and Stimwave, Neurosigma Inc., Synapse Biomedical Inc., Abbott Laboratories, Beijing PINS Medical Co., Ltd, Cirtec Medical Corporation, Gimer Medical, Bluewind Medical, Bioinduction, Greatbatch, Inc., Saluda Medical Pty Ltd.
Excimer and Femtosecond Ophthalmic Lasers Market Segments
Product:
Excimer Laser
Femtosecond Laser
Application:
Refractive Surgery
Cataract Surgery
Capsulotomy
Trabeculoplasty
Diagnosis
End User:
Hospitals
Ambulatory Surgical Centers
Ophthalmology Clinics
More Insights into the Excimer and Femtosecond Ophthalmic Lasers Market
The U.S. is expected to dominate the global excimer and femtosecond ophthalmic lasers market as it accounted for more around 81.8% of the North American Excimer and Femtosecond Ophthalmic Lasers Market in 2021 and it is poised to grow at a robust pace during the next ten years.
Information Source:
https://www.futuremarketinsigh....ts.com/reports/excim
Kao
Komentar
Udio
Kao
Komentar
Udio
Ambulatory Surgical Centers Market Witness a Spike in Growth Pace Recent Improvements in Pricing Models: FMI
The Ambulatory Surgical Centers Market was worth US$ 85.4 billion in 2020 and it is anticipated to grow at a 3.9% CAGR from 2021 to 2031 to reach US$ 130.6 billion by 2031.
The report broadly segments the global ambulatory surgical centres market on the basis of centre type, modality, services speciality area and region. Based on centre type, the global ambulatory surgical centres market has been segmented into single speciality centres and multispecialty centres.
The rising number of Coronavirus cases amid the COVID-19 pandemic has impelled the demand for external treatment facilities among hospitals, which in turn is stimulating the global ambulatory surgical centers market outlook. However, high costs associated with deployment along with heavy infrastructural investments are expected to impede the industry growth throughout the study period.
Key Insights from FMI’s Report on the Ambulatory Surgical Centres Market
Growing focus on containment of healthcare costs and increased Medicare spending on ASCs are driving the global ambulatory surgical centre market.
Number of outpatient surgeries have increased significantly in the recent years, thereby impacting the ambulatory surgical centres market worldwide. Also, a significant share of outpatient procedures have shifted from hospitals to free-standing ambulatory surgical facilities over the same period.
Over the last decade, various constitutes across healthcare continuum, including private insurance companies, self-insured employers, and government payers, are implementing meaningful cost-containment measures.
Leading manufacturers are focussing on setting up manufacturing facilities in emerging markets and this would substantially increase the chances of growth, as there would be no import-export glitches.
Surgical Services Segment Dominates by Service Type
Surgical services segment is estimated to dominate the global ambulatory surgical centres market by service type with higher value share of the market by 2017 end. Surgical services segment is expected to reach US$ 77,664.3 Mn by 2027 end and will grow at a CAGR of 4.2% over the forecast period.
Gastroenterology Segment is the Most Attractive Segment by Specialty Area
Among speciality areas, gastroenterology is expected to dominate the global ambulatory surgical centres market in terms of value share during the forecast period. Gastroenterology is expected to grow at a CAGR of 4.7% over the forecast period.
Ambulatory Surgical Centres Market: Key Players
Key competitors covered in the report include AmSurg Corp., HCA Holdings, Inc., Tenet Healthcare, Surgical Care Affiliates, Inc., Ambulatory Surgical Centers of America, Surgery Partners, Medical Facilities Corporation, Healthway Medical Group and Community Health Systems, Inc.
North America Will Continue to Grow at an Exponential Rate
FMI has analysed the ambulatory surgical centres market across seven key regions namely North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). North America is expected to dominate the market value share for ambulatory surgical centres and is expected to reach US$ 61,588.4 Mn by 2027 end. The Western Europe market is expected to account for the second largest market value share, followed by APEJ. North America and Europe are collectively expected to constitute more than 82% of the market share over the forecast period. MEA is predicted to be the least attractive region in the global ambulatory surgical centres market.
Hospital-Based Ambulatory Surgical Centre Segment Accounts for Higher Market Demand
Among modality types, hospital-based ambulatory surgical centre segment is expected to dominate the global ambulatory surgical centres market with 59.5% value share in 2017. Hospital-based ambulatory surgical centre segment is expected to reach a market value of US$ 69,700.4 Mn by 2027 end, growing with a CAGR of 4.4% over the forecast period.
Multispecialty Centres Segment is the Most Lucrative Segment
Multispecialty centres segment is estimated to dominate the ambulatory surgical centres market by product type with 65% value share of the market by 2017 end. Multispecialty centres segment is expected to reach US$ 76,028.6 Mn by 2027 end and will grow at the fastest CAGR of 4.4% over the forecast period.
Ambulatory Surgical Center by Category
By Centers Type:
Single Specialty Centers
Multispecialty Centers
By Modality:
Hospital-Based Ambulatory Surgical Center
Freestanding Ambulatory Surgical Center
By Services:
Diagnostic Services
Surgical Services
By Specialty Area:
Gastroenterology
Ophthalmology
Orthopaedics
Pain/Neurology
Urology
Dermatology
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)
Information Source:
https://www.futuremarketinsigh....ts.com/reports/ambul
Kao
Komentar
Udio
Kao
Komentar
Udio
Kao
Komentar
Udio
Showing 58724 out of 72459